Ana Godec
Forskningsassistent vid Institutionen för farmaci; Biologiska läkemedel; ProDDe
- E-post:
- ana.godec@uu.se
- Besöksadress:
- Biomedicinskt Centrum BMC, Husargatan 3
- Postadress:
- Box 580
751 23 UPPSALA
Ladda ned kontaktuppgifter för Ana Godec vid Institutionen för farmaci; Biologiska läkemedel; ProDDe

Publikationer
Senaste publikationer
-
Ingår i Biomedicine and Pharmacotherapy, 2025
- DOI för Somatostatin therapy, neprilysin activation, and amyloid beta reduction: A novel approach for Alzheimer's treatment
- Ladda ner fulltext (pdf) av Somatostatin therapy, neprilysin activation, and amyloid beta reduction: A novel approach for Alzheimer's treatment
-
Updated transient gene expression protocol in Expi293F cells using PEI
Ingår i Frontiers in Bioengineering and Biotechnology, 2025
- DOI för Updated transient gene expression protocol in Expi293F cells using PEI
- Ladda ner fulltext (pdf) av Updated transient gene expression protocol in Expi293F cells using PEI
-
Ingår i Neurotherapeutics, 2025
- DOI för Lowering the affinity of single-chain monovalent BBB shuttle scFc-scFv8D3 prolongs its half-life and increases brain concentration
- Ladda ner fulltext (pdf) av Lowering the affinity of single-chain monovalent BBB shuttle scFc-scFv8D3 prolongs its half-life and increases brain concentration
-
Ingår i Scientific Reports, 2024
- DOI för A shorter linker in the bispecific antibody RmAb158-scFv8D3 improves TfR-mediated blood-brain barrier transcytosis in vitro
- Ladda ner fulltext (pdf) av A shorter linker in the bispecific antibody RmAb158-scFv8D3 improves TfR-mediated blood-brain barrier transcytosis in vitro
-
A charged tail on anti-α-Synuclein antibodies does not enhance their affinity to α-Synuclein fibrils
Ingår i PLOS ONE, 2024
- DOI för A charged tail on anti-α-Synuclein antibodies does not enhance their affinity to α-Synuclein fibrils
- Ladda ner fulltext (pdf) av A charged tail on anti-α-Synuclein antibodies does not enhance their affinity to α-Synuclein fibrils
Alla publikationer
Artiklar i tidskrift
-
Ingår i Biomedicine and Pharmacotherapy, 2025
- DOI för Somatostatin therapy, neprilysin activation, and amyloid beta reduction: A novel approach for Alzheimer's treatment
- Ladda ner fulltext (pdf) av Somatostatin therapy, neprilysin activation, and amyloid beta reduction: A novel approach for Alzheimer's treatment
-
Updated transient gene expression protocol in Expi293F cells using PEI
Ingår i Frontiers in Bioengineering and Biotechnology, 2025
- DOI för Updated transient gene expression protocol in Expi293F cells using PEI
- Ladda ner fulltext (pdf) av Updated transient gene expression protocol in Expi293F cells using PEI
-
Ingår i Neurotherapeutics, 2025
- DOI för Lowering the affinity of single-chain monovalent BBB shuttle scFc-scFv8D3 prolongs its half-life and increases brain concentration
- Ladda ner fulltext (pdf) av Lowering the affinity of single-chain monovalent BBB shuttle scFc-scFv8D3 prolongs its half-life and increases brain concentration
-
Ingår i Scientific Reports, 2024
- DOI för A shorter linker in the bispecific antibody RmAb158-scFv8D3 improves TfR-mediated blood-brain barrier transcytosis in vitro
- Ladda ner fulltext (pdf) av A shorter linker in the bispecific antibody RmAb158-scFv8D3 improves TfR-mediated blood-brain barrier transcytosis in vitro
-
A charged tail on anti-α-Synuclein antibodies does not enhance their affinity to α-Synuclein fibrils
Ingår i PLOS ONE, 2024
- DOI för A charged tail on anti-α-Synuclein antibodies does not enhance their affinity to α-Synuclein fibrils
- Ladda ner fulltext (pdf) av A charged tail on anti-α-Synuclein antibodies does not enhance their affinity to α-Synuclein fibrils
-
Ingår i Alzheimer's Research & Therapy, 2022
- DOI för Blood-brain barrier penetrating neprilysin degrades monomeric amyloid-beta in a mouse model of Alzheimer’s disease
- Ladda ner fulltext (pdf) av Blood-brain barrier penetrating neprilysin degrades monomeric amyloid-beta in a mouse model of Alzheimer’s disease